#SME perspective by C.Kampf @MarinusPharma highlights the #GPL proposal to launch product in 2 years of approval is the most problematic, as market access is not in hands of company entirely. For small company it could mean no launch at all..@DIA_Europe @EFPIA
0
1
6
296
1
Download Image